That’s listed among SpaceX’s “substantial capital expenditures” in the S-1 registration filed ahead of its IPO, reports Reuters.
The space / AI / social network company is working with Intel to build its “Terafab” chip plant that Musk said could rely on a new 14A chip manufacturing process.
















